BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19394333)

  • 1. Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry.
    Matsumura T; Hu Z; Kato T; Dreux M; Zhang YY; Imamura M; Hiraga N; Juteau JM; Cosset FL; Chayama K; Vaillant A; Liang TJ
    Gastroenterology; 2009 Aug; 137(2):673-81. PubMed ID: 19394333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.
    Noordeen F; Vaillant A; Jilbert AR
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5291-8. PubMed ID: 23939902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
    Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
    J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
    Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
    Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gumming up the works: DNA polymers as HCV entry inhibitors.
    Counihan NA; Lindenbach BD
    Gastroenterology; 2009 Aug; 137(2):427-30. PubMed ID: 19563837
    [No Abstract]   [Full Text] [Related]  

  • 7. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry.
    Behrendt P; Perin P; Menzel N; Banda D; Pfaender S; Alves MP; Thiel V; Meuleman P; Colpitts CC; Schang LM; Vondran FWR; Anggakusuma ; Manns MP; Steinmann E; Pietschmann T
    Antiviral Res; 2017 Nov; 147():19-28. PubMed ID: 28923507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
    Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection.
    Vaillant A
    Antiviral Res; 2016 Sep; 133():32-40. PubMed ID: 27400989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.
    Lee AM; Rojek JM; Gundersen A; Ströher U; Juteau JM; Vaillant A; Kunz S
    Virology; 2008 Mar; 372(1):107-17. PubMed ID: 18022208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small molecule inhibitor of hepatitis C virus entry.
    Baldick CJ; Wichroski MJ; Pendri A; Walsh AW; Fang J; Mazzucco CE; Pokornowski KA; Rose RE; Eggers BJ; Hsu M; Zhai W; Zhai G; Gerritz SW; Poss MA; Meanwell NA; Cockett MI; Tenney DJ
    PLoS Pathog; 2010 Sep; 6(9):e1001086. PubMed ID: 20838466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.
    Xia Y; Cheng X; Blossey CK; Wisskirchen K; Esser K; Protzer U
    J Immunol Res; 2017; 2017():4828936. PubMed ID: 28367455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.
    Takebe Y; Saucedo CJ; Lund G; Uenishi R; Hase S; Tsuchiura T; Kneteman N; Ramessar K; Tyrrell DL; Shirakura M; Wakita T; McMahon JB; O'Keefe BR
    PLoS One; 2013; 8(5):e64449. PubMed ID: 23700478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.